Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2021-01-15
Product name:
HEMOSATE ULTRA HS0125
DIN:
02413876
Product Monograph/Veterinary Labelling:
Date:
2021-01-15
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
CHIEF MEDICAL SUPPLIES LTD
411 19th St Se
Calgary
Alberta
Canada
T2E 6J7
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Haemodialysis
Number of active ingredient(s):
6
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
40:34.00* See footnote6
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05ZA HEMODIALYTICS, CONCENTRATES
Active ingredient group (AIG) number:See footnote5
0652910001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| CALCIUM CHLORIDE | 6.24 G / L |
| CITRIC ACID | 6.91 G / L |
| DEXTROSE | 49.5 G / L |
| MAGNESIUM CHLORIDE | 2.14 G / L |
| SODIUM ACETATE | 1.11 G / L |
| SODIUM CHLORIDE | 263 G / L |